INTERCEPT PHARMACEUTICALS, INC. Underwriting Agreements
7 Contracts & Agreements
- Convertible Notes Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies... (Filed With SEC on May 14, 2019)
- Common Stock Underwriting Agreement, dated May 9, 2019, between Intercept Pharmaceuticals, Inc. and Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and Jefferies LLC,... (Filed With SEC on May 14, 2019)
- Underwriting Agreement, dated April 5, 2018, between Intercept Pharmaceuticals, Inc. and Credit Suisse Securities (USA) LLC and Jefferies LLC (Filed With SEC on April 10, 2018)
- INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) $400,000,000 3.25% Convertible Senior Notes due 2023 UNDERWRITING AGREEMENT (Filed With SEC on July 6, 2016)
- INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) 1,200,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 2, 2015)
- INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) 1,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 6, 2015)
- INTERCEPT PHARMACEUTICALS, INC. (a Delaware corporation) [l]Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on September 27, 2012)
